Decision With Precision

Promoting Personalised Medicine By Bringing Functional Proteomics To Pathology

QF-Pro®, a transformative platform that unveils post-translational modifications and protein-protein interactions in pathology samples

FASTBASE´s companion diagnostics platform, QF-Pro®, quantifies protein-protein interactions and protein post-translational modifications in single cell and fixed tissue samples. By design the platform has built in specificity and preserves the morphological integrity and cellular heterogeneity of the tissue. It can be exploited for pharmacodynamics, precision diagnostics and prognostics designed to impact clinical practice.

Learn More About QF-Pro®

Powerful Biomarkers for better Treatment Stratification

Protein complexes and protein post translational modifications (PTM) characterise functional states of proteins pertinent to disease. In the microenvironment of a tissue, assessments of these attributes provide markers of disease that are more relevant than simple expression levels of proteins. The QF-Pro® platform can deliver on this information, providing a better route to treatment decisions in cancer, inflammation and immune disorders.

Learn More About our Biomarkers

Meet the Fastbase Team

Our team is composed of industrial experts and world-class scientists with common values and a strong shared vision: better diagnostics for better patient outcomes. Our depth and breadth of expertise in advanced molecular diagnostics, along with the considerable academic and research expertise of our founders and our exclusive proprietary technologies, positions us at the forefront of precision pathology.

Learn More About our Team


FASTBASE Launch Equity Crowd Funding Campaign

| News | No Comments
We have launched an exciting crowdfunding opportunity with Crowd Cube in the UK! Our investment round is currently open privately for early investment opportunities and can be found here:…

Looking at the future II: next challenges in cancer treatment

| News | No Comments
Last month we talked about how important is to have an accurate diagnosis for cancer management and the improvements we are witnessing in this field. Today, we will discuss about…
Future of Cancer diagnosis

Looking at the future: next challenges in cancer diagnosis

| News | No Comments
Despite cancer is still one of the most challenging threats of the XXI century, in the last decades we have witnessed a great improvement both in diagnosis methods and treatments.…

Are there cancer stem cells?

| News, Sin categoría | No Comments
According to the American National Institute of Health (NIH) a tumor is defined as an abnormal mass of tissue that appears when cells multiply more than expected or do not…


When joining us, you have a unique opportunity to be the one. You are becoming part of the team that’s shaping the next innovation platform for diagnostics, right here and now. You will join a strong, values-driven organization focused on our people and in advancing cutting-edge science.

Join The Fastbase Team

Contact Us.

Astondo bidea, Kabi 612
Scientific and Technology Park of Bizkaia
48160 Derio, Spain